methimazole and Adrenal-Hyperplasia--Congenital

methimazole has been researched along with Adrenal-Hyperplasia--Congenital* in 1 studies

Other Studies

1 other study(ies) available for methimazole and Adrenal-Hyperplasia--Congenital

ArticleYear
Thyrotoxic periodic paralysis with Graves' disease leading to the discovery of a hidden nonclassic 11β hydroxylase deficiency.
    Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:1

    11β hydroxylase deficiency (OHD) is one of the main causes of congenital adrenal hyperplasia. There have been only a few reported cases of nonclassic 11β OHD, a milder form of the disease. It is difficult to detect occult nonclassic 11β OHD because patients present with no or mild symptoms. We herein present a case of thyrotoxic periodic paralysis (TPP) with Graves' disease leading to the discovery of a hidden nonclassic 11β OHD. In this case, increased levels of thyroid hormone seem to have induced symptoms of occult nonclassic 11β OHD and aggravated TPP.

    Topics: Adrenal Hyperplasia, Congenital; Diagnosis, Differential; Drug Therapy, Combination; Graves Disease; Humans; Hypokalemic Periodic Paralysis; Male; Methimazole; Mutation; Polymerase Chain Reaction; Polymorphism, Genetic; Potassium; Propranolol; Risk Assessment; Severity of Illness Index; Steroid 11-beta-Hydroxylase; Thyrotoxicosis; Tomography, X-Ray Computed; Treatment Outcome; Young Adult

2013